EFFECTS OF GALANIN ON PASSIVE-AVOIDANCE RESPONSE, ELEVATED PLUS-MAZE LEARNING, AND SPONTANEOUS-ALTERNATION PERFORMANCE IN MICE

被引:43
作者
UKAI, M
MIURA, M
KAMEYAMA, T
机构
[1] Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya
关键词
GALANIN; MEMORY; PHYSOSTIGMINE; OXOTREMORINE;
D O I
10.1016/0196-9781(95)02009-L
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was done to characterize the effects of intracerebroventricular injection of galanin (GAL) on memory processes by observing passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. An intermediate dose (3 mu g) of GAL (3 mu g) significantly decreased step-down latency of passive avoidance response when given 15 min before training, whereas in particular the middle doses (0.3 and 1 mu g) of GAL significantly decreased it when given 15 min before retention tests. However, GAL (0.3-10 mu g) was ineffective when given immediately after training. Physostigmine (0.2 mg/kg), a cholinesterase inhibitor, and oxotremorine (0.01 and 0.03 mg/kg), a cholinergic agonist, significantly inhibited the shortening of step-down latency induced by GAL (0.3 mu g) administered 15 min before retention tests, indicating the involvement of cholinergic dysfunction in the GAL (0.3 mu g)-induced shortening of step-down latency. In contrast, GAL (0.3-3 mu g) failed to influence transfer latency in elevated plus-maze learning or percent alternation in spontaneous alternation performance. These results suggest that the activation of cholinergic neurons improves memory dysfunctions induced by GAL, which primarily impairs retrieval processes of memory. The lack of effects of GAL on the elevated plus-maze learning and spontaneous alternation performance may result from the selective effects of GAL in different learning paradigms.
引用
收藏
页码:1283 / 1286
页数:4
相关论文
共 28 条
[1]   ANXIOLYTIC-LIKE ACTION OF CENTRALLY ADMINISTERED GALANIN [J].
BING, O ;
MOLLER, C ;
ENGEL, JA ;
SODERPALM, B ;
HEILIG, M .
NEUROSCIENCE LETTERS, 1993, 164 (1-2) :17-20
[2]   CO-EXISTENCE OF GALANIN AND ACETYLCHOLINE - IS GALANIN INVOLVED IN MEMORY PROCESSES AND DEMENTIA [J].
CRAWLEY, JN ;
WENK, GL .
TRENDS IN NEUROSCIENCES, 1989, 12 (08) :278-282
[3]   GALANIN BLOCKS THE SLOW CHOLINERGIC EPSP IN CA1 PYRAMIDAL NEURONS FROM VENTRAL HIPPOCAMPUS [J].
DUTAR, P ;
LAMOUR, Y ;
NICOLL, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (02) :355-360
[4]   GALANIN INHIBITS ACETYLCHOLINE-RELEASE IN THE VENTRAL HIPPOCAMPUS OF THE RAT - HISTOCHEMICAL, AUTORADIOGRAPHIC, INVIVO, AND INVITRO STUDIES [J].
FISONE, G ;
WU, CF ;
CONSOLO, S ;
NORDSTROM, O ;
BRYNNE, N ;
BARTFAI, T ;
MELANDER, T ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7339-7343
[5]   GALANIN IN THE MEDIAL SEPTAL AREA IMPAIRS WORKING MEMORY [J].
GIVENS, BS ;
OLTON, DS ;
CRAWLEY, JN .
BRAIN RESEARCH, 1992, 582 (01) :71-77
[6]  
GRAY JA, 1982, NEUROSCIENCE BIOBEHA, V7, P119
[7]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[8]   UTILITY OF AN ELEVATED PLUS-MAZE FOR THE EVALUATION OF MEMORY IN MICE - EFFECTS OF NOOTROPICS, SCOPOLAMINE AND ELECTROCONVULSIVE SHOCK [J].
ITOH, J ;
NABESHIMA, T ;
KAMEYAMA, T .
PSYCHOPHARMACOLOGY, 1990, 101 (01) :27-33
[9]  
ITOH J, 1994, J PHARMACOL EXP THER, V269, P15
[10]   DYNORPHIN A-(1-13) MARKEDLY IMPROVES SCOPOLAMINE-INDUCED IMPAIRMENT OF SPONTANEOUS-ALTERNATION PERFORMANCE IN MICE [J].
ITOH, J ;
UKAI, M ;
KAMEYAMA, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (03) :341-345